Opinion Review
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1551-1560
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1551
New drugs for the treatment of metastatic colorectal cancer
Sara Cherri, Michela Libertini, Alberto Zaniboni
Sara Cherri, Michela Libertini, Alberto Zaniboni, Department of Oncology, Fondazione Poliambulanza, Brescia 25124, Italy
Author contributions: Cherri S and Libertini M drafted the manuscript; Zaniboni A revised this manuscript; All the authors approved the final version.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sara Cherri, MD, Medical Assistant, Department of Oncology, Fondazione Poliambulanza, Via L. Bissolati 57, Brescia 25124, Italy. sara.cherri@poliambulanza.it
Received: April 2, 2021
Peer-review started: April 2, 2021
First decision: June 23, 2021
Revised: July 1, 2021
Accepted: September 8, 2021
Article in press: September 8, 2021
Published online: November 15, 2021
Core Tip

Core Tip: Although metastatic colorectal cancer (CRC) is a relevant oncological issue, few drugs have changed clinical practice in the last decade. In fact, there are many difficulties in the development of new drugs closely related to the biology of CRC; however, improved knowledge of the molecular biology of this cancer has led to a few steps forward and the hope for more targeted cancer treatments for metastatic CRC patients in the near future.